Author

Shaun M Flint

Observed names: S Flint, S. Flint, S. M. Flint, S.M. Flint, Shaun Flint, Shaun M. Flint

Observed institutions: Statens Serum Institut, The Royal Melbourne Hospital, Inserm, GlaxoSmithKline (United Kingdom), University of Cambridge, Université Paris-Saclay, The Royal Free Hospital, Cambridge University Hospitals NHS Foundation Trust, National Institute for Health and Care Research, Government of the Northern Territory, Vifor Pharma (Switzerland), Northern Territory Health Services, Addenbrooke's Hospital, Inflammation, Microbiome and Immunosurveillance, NIHR Cambridge Biomedical Research Centre, University College London, Imperial College London, Medical Research Council

ORCID: 0000-0002-5282-9334

Observed ORCID: 0000-0002-5282-9334

OpenAlex ID: A5070488647

A Type I Interferon Transcriptional Signature Precedes Autoimmunity in Children Genetically at Risk for Type 1 Diabetes

2014 · Ricardo C. Ferreira, Hui Guo, et al. · Diabetes · 324

PDF

Disproportionate impact of pandemic (H1N1) 2009 influenza on Indigenous people in the Top End of Australia's Northern Territory

2010 · Shaun M Flint, Joshua S Davis, et al. · The Medical Journal of Australia · 116

PDF

Successful ABO-Incompatible Kidney Transplantation with Antibody Removal and Standard Immunosuppression

2011 · S.M. Flint, R.G. Walker, et al. · American Journal of Transplantation · 115

PDF

Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis

2013 · Ruth J. Pepper, Sally Hamour, et al. · Kidney International · 109

PDF

Peripheral Immune Cell Populations Associated with Cognitive Deficits and Negative Symptoms of Treatment-Resistant Schizophrenia

2016 · Emilio Fernandez-Egea, Petra E. Vértes, et al. · PLoS ONE · 108

PDF

Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial

2018 · Gemma D Banham, Shaun M Flint, et al. · The Lancet · 94

Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity

2017 · David C. Thomas, Simon Clare, et al. · The Journal of Experimental Medicine · 69

PDF

The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis

2020 · Christel Wilkinson, Robert B. Henderson, et al. · Arthritis Research & Therapy · 41

PDF

Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis

2022 · Christopher P Denton, Francesco del Galdo, et al. · Rheumatology · 38

PDF

Comparison of gene expression microarray data with count-based RNA measurements informs microarray interpretation

2014 · Arianne C Richard, Paul A Lyons, et al. · BMC Genomics · 38

PDF

NBEAL2 is required for neutrophil and NK cell function and pathogen defense

2017 · John M. Sowerby, David C. Thomas, et al. · Journal of Clinical Investigation · 37

Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis

2021 · Kristina Elizabeth Neergaard Clark, Corrado Campochiaro, et al. · Annals of the Rheumatic Diseases · 34

Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases

2016 · Shaun M Flint, Vojislav Jovanovic, et al. · RMD Open · 29

PDF

Emerging concepts in the pathogenesis of antineutrophil cytoplasmic antibody-associated vasculitis

2015 · Shaun M. Flint, Eoin F. McKinney, et al. · Current Opinion in Rheumatology · 25

PDF

Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options

2017 · Romy Strauß, Thomas Rose, et al. · Journal of Molecular Medicine · 24

Glucocorticoid-Induced Leucine Zipper Protein Controls Macropinocytosis in Dendritic Cells

2016 · Joseph Calmette, Matthieu Bertrand, et al. · The Journal of Immunology · 21

Histological and Extended Clinical Outcomes After ABO-Incompatible Renal Transplantation Without Splenectomy or Rituximab

2016 · Kevin V. Chow, Shaun M. Flint, et al. · Transplantation · 21

Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study

2022 · Kristina E N Clark, Eszter Csomor, et al. · The Lancet Rheumatology · 19

Anti–LAMP-2 Autoantibodies in ANCA-Associated Pauci-Immune Glomerulonephritis

2012 · Shaun M. Flint, Caroline O.S. Savage · Journal of the American Society of Nephrology · 18

A distinct plasmablast and naive B-cell phenotype in primary immune thrombocytopenia

2016 · S. M. Flint, A. Gibson, et al. · Haematologica · 16

PDF

Increased Iron Requirement in Hemodialysis Patients on Antiplatelet Agents or Warfarin

2009 · Shaun Flint, Emma Taylor, et al. · Nephron Clinical Practice · 10

Transinteractome analysis reveals distinct niche requirements for isotype‐based plasma cell subsets in the bone marrow

2023 · Amélie Bonaud, Pierre Larraufie, et al. · European Journal of Immunology · 9

PDF

The Contribution of Transcriptomics to Biomarker Development in Systemic Vasculitis and SLE

2015 · Shaun Flint, Eoin McKinney, et al. · Current Pharmaceutical Design · 9

PDF

The early experience of pandemic (H1N1) 2009 influenza in the Northern Territory, Australia

2009 · Shaun Flint, Jiunn-Yi Su, et al. · 6

Alloimmune haemolysis in a renal transplant recipient receiving sirolimus

2008 · A. J. Hedley, S. Flint, et al. · Clinical Kidney Journal · 5

PDF

Works count: 44

Citation count: 1,345

H-index: 18

I10-index: 21